# FDA Inspection 1156399 - Octapharma Plasma Inc - November 04, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/82ff97f6-eb7c-4cae-91a3-05c361797cff
Source feed: FDA_Inspections

> FDA Inspection 1156399 for Octapharma Plasma Inc on November 04, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1156399
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-11-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1156399 - 2021-11-04](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/627c30e1-ed71-4b3b-9f9c-a72a3d7c3d2e)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/6f06f7b1-11bd-41b7-95ce-afb0b3fe55a3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d